Tuberc Respir Dis > Epub ahead of print |
|
Authors’ Contributions
Conceptualization: all authors. Methodology: Lee JK, An H, Koh Y. Formal analysis: Lee JK, Lee CH. Data curation: Lee JK, Lee CH. Software: Lee JK, An H, Koh Y. Validation: Lee JK. Investigation: Lee JK, An H. Writing - original draft preparation: Lee JK, Lee CH. Writing - review and editing: all authors. Approval of final manuscript: all authors.
Characteristic | Non-current smoker (n=91) | Current smoker (n=34) | p-value* | COPD GOLD 1 (n=16) | COPD GOLD 2-4 (n=109) | p-value† |
---|---|---|---|---|---|---|
Age, yr | 68.3±8.1 | 67.5±8.4 | 0.296 | 71.1±9.1 | 67.7±7.9 | 0.224 |
Male sex | 79 (86.8) | 33 (97.1) | 0.096 | 14 (87.5) | 98 (89.9) | 0.769 |
Body mass index, kg/m2 | 23.8±3.0 | 23.6±3.4 | 0.498 | 23.7±2.4 | 23.7±3.2 | 0.748 |
Smoking history | <0.001 | 0.555 | ||||
Never- smoker | 21 (23.1) | 0 | 3 (18.8) | 18 (16.5) | ||
Ex-smoker | 70 (76.9) | 0 | 7 (43.8) | 63 (57.8) | ||
Current smoker | 0 | 34 (100) | 6 (37.5) | 28 (25.7) | ||
Smoking intensity, pack-yr | 40.5±34.4 | 48.9±18.4 | 0.067 | 39.2±26.6 | 43.3±31.7 | 0.784 |
SGRQ score | 36.5±16.5 | 35.0±13.2 | 0.681 | 38.5±18.1 | 35.7±15.3 | 0.628 |
CAT score | 17.2±7.5 | 15.9±7.41 | 0.296 | 18.1±6.8 | 16.7±7.5 | 0.332 |
mMRC grade | 1.36±0.77 | 1.34±0.68 | 0.971 | 1.31±0.95 | 1.37±0.72 | 0.512 |
Lung function | ||||||
FEV1, L | 1.51±0.47 | 1.57±0.46 | 0.428 | 2.14±0.49 | 1.43±0.39 | <0.001 |
FEV1, % predicted | 61.7±17.9 | 62.5±18.1 | 0.739 | 93.6±10.9 | 57.3±13.5 | <0.001 |
FVC, L | 3.36±0.82 | 3.43±0.68 | 0.407 | 3.82±0.82 | 3.31±0.76 | 0.006 |
FVC, % predicted | 92.9±16.7 | 93.1±17.9 | 0.786 | 114.1±16.6 | 89.8±14.7 | <0.001 |
FEV1/FVC ratio | 0.45±0.12 | 0.46±0.10 | 0.673 | 0.56±0.08 | 0.44±0.11 | <0.001 |
TLC, % predicted | 115.5±16.2 | 110.1±14.5 | 0.063 | 114.0±15.4 | 114.1±16.0 | 0.790 |
RV, % predicted | 125.5±36.1 | 115.1±30.8 | 0.199 | 119.8±25.9 | 123.1±36.1 | 0.773 |
DLCO, % predicted | 80.8±20.7 | 78.5±16.5 | 0.816 | 85.3±18.1 | 79.4±19.8 | 0.153 |
6-minute walking distance | 502.6±470.8 | 455.4±83.2 | 0.850 | 470.8±77.6 | 492.5±431.8 | 0.703 |
Acute exacerbation | ||||||
Mild | 0.37±1.42 | 0.09±0.38 | 0.449 | 0±0 | 0.34±1.31 | 0.186 |
Moderate | 0.84±1.63 | 0.74±1.29 | 0.955 | 1.06±1.34 | 0.77±1.57 | 0.168 |
Severe | 0.13±0.43 | 0.06±0.24 | 0.463 | 0±0 | 0.13±0.41 | 0.185 |
COPD: chronic obstructive pulmonary disease; GOLD: Global Initiative for Obstructive Diseases; SGRQ: St. George’s Respiratory Questionnaire; CAT: COPD assessment test; mMRC: modified Medical Research Council; FEV1: forced expiratory volume in 1 second; FVC: forced vital capacity; TLC: total lung capacity; RV: residual volume; DLCO: diffusing capacity of the lungs for carbon monoxide.
Variable | Non-current smoker (n=91) | Current smoker (n=34) | p-value* | COPD GOLD 1 (n=16) | COPD GOLD 2-4 (n=109) | p-value† |
---|---|---|---|---|---|---|
All genes | 20 (22.0) | 12 (35.3) | 0.131 | 3 (18.8) | 29 (26.6) | 0.503 |
DTAP | 13 (14.3) | 10 (29.4) | 0.053 | 2 (12.5) | 21 (19.3) | 0.516 |
DTA | 13 (14.3) | 9 (26.5) | 0.113 | 1 (6.3) | 21 (19.3) | 0.204 |
DTP | 10 (11.0) | 9 (26.5) | 0.033 | 1 (6.3) | 18 (16.5) | 0.288 |
DT | 10 (11.0) | 8 (23.5) | 0.077 | 0 | 18 (16.5) | 0.080 |
DNMT3A | 5 (5.5) | 6 (17.6) | 0.034 | 0 | 11 (10.1) | 0.185 |
TET2 | 5 (5.5) | 2 (5.9) | 0.933 | 0 | 7 (6.4) | 0.299 |
ASXL1 | 5 (5.5) | 1 (2.9) | 0.554 | 1 (6.3) | 5 (4.6) | 0.772 |
PPM1D | 0 | 2 (5.9) | 0.020 | 1 (6.3) | 1 (0.9) | 0.114 |
CHIP: clonal hematopoiesis of indeterminate potential; COPD: chronic obstructive pulmonary disease; GOLD: Global Initiative for Obstructive Diseases; DTAP: combination of DNMT3A, TET2, ASXL1, and PPM1D; DTA: combination of DNMT3A, TET2, and ASXL1; DTP: combination of DNMT3A, TET2, and PPM1D; DT: combination of DNMT3A and TET2; DNMT3A: DNA methyltransferase 3 alpha; TET2: tet methylcytosine dioxygenase 2; ASXL1: ASXL transcriptional regulator 1; PPM1D: protein phosphatase, Mg2+/Mn2+ dependent 1D.
Variable |
Univariable |
Multivariable |
||
---|---|---|---|---|
OR (95% CI) | p-value | aOR (95% CI)* | p-value | |
All genes | 1.94 (0.82−4.58) | 0.132 | 2.04 (0.84−4.94) | 0.115 |
DTAP | 2.50 (0.97−6.42) | 0.057 | 2.41 (0.92−6.31) | 0.072 |
DTA | 2.16 (0.83−5.65) | 0.117 | 2.06 (0.78−5.47) | 0.147 |
DTP | 2.92 (1.07−7.97) | 0.037 | 2.80 (1.01−7.79) | 0.048 |
DT | 2.49 (0.89−6.98) | 0.082 | 2.37 (0.83−6.74) | 0.106 |
DNMT3A | 3.69 (1.04−13.0) | 0.043 | 4.03 (1.09−14.0) | 0.037 |
TET2 | 1.08 (0.20−5.82) | 0.933 | 0.89 (0.16−4.88) | 0.890 |
ASXL1 | 0.52 (0.06−4.63) | 0.559 | 0.49 (0.06−4.40) | 0.524 |
PPM1D | - | - | - | - |
CHIP: clonal hematopoiesis of indeterminate potential; OR: odds ratio; CI: confidence interval; aOR: adjusted odds ratio; DTAP: combination of DNMT3A, TET2, ASXL1, and PPM1D; DTA: combination of DNMT3A, TET2, and ASXL1; DTP: combination of DNMT3A, TET2, and PPM1D; DT: combination of DNMT3A and TET2; DNMT3A: DNA methyltransferase 3 alpha; TET2: tet methylcytosine dioxygenase 2; ASXL1: ASXL transcriptional regulator 1; PPM1D: protein phosphatase, Mg2+/Mn2+ dependent 1D.
Variable |
Univariable |
Multivariable |
||
---|---|---|---|---|
OR (95% CI) | p-value | aOR (95% CI)* | p-value | |
All genes | 1.57 (0.42−5.91) | 0.504 | 1.99 (0.50−8.02) | 0.332 |
DTAP | 1.67 (0.35−7.92) | 0.518 | 2.33 (0.44−12.4) | 0.324 |
DTA | 3.58 (0.45−28.6) | 0.229 | 4.80 (0.54−42.4) | 0.158 |
DTP | 2.97 (0.37−23.9) | 0.307 | 4.12 (0.45−37.6) | 0.210 |
DT | - | - | - | - |
DNMT3A | - | - | - | - |
TET2 | - | - | - | - |
ASXL1 | 0.72 (0.08−6.60) | 0.772 | 0.86 (0.09−8.49) | 0.896 |
PPM1D | 0.14 (0.01−2.34) | 0.171 | 0.25 (0.01−5.15) | 0.372 |
CHIP: clonal hematopoiesis of indeterminate potential; COPD: chronic obstructive pulmonary disease; OR: odds ratio; CI, confidence interval; aOR, adjusted odds ratio; DTAP: combination of DNMT3A, TET2, ASXL1, and PPM1D; DTA: combination of DNMT3A, TET2, and ASXL1; DTP: combination of DNMT3A, TET2, and PPM1D; DT: combination of DNMT3A and TET2; DNMT3A: DNA methyltransferase 3 alpha; TET2: tet methylcytosine dioxygenase 2; ASXL1: ASXL transcriptional regulator 1; PPM1D: protein phosphatase, Mg2+/Mn2+ dependent 1D.
All analysis were adjusted by age, sex, and smoking intensity.
CHIP: clonal hematopoiesis of indeterminate potential; SE: standard error; aOR: adjusted odds ratio; CI: confidence interval; DTAP: combination of DNMT3A, TET2, ASXL1, and PPM1D; DTA: combination of DNMT3A, TET2, and ASXL1; DTP: combination of DNMT3A, TET2, and PPM1D; DT: combination of DNMT3A and TET2; DNMT3A: DNA methyltransferase 3 alpha; TET2: tet methylcytosine dioxygenase 2; ASXL1: ASXL transcriptional regulator 1; PPM1D: protein phosphatase, Mg2+/Mn2+ dependent 1D.
Jung-Kyu Lee
https://orcid.org/0000-0001-5060-7255
Chang-Hoon Lee
https://orcid.org/0000-0001-9960-1524